16 Confirmed Participants in 2018
Aesica, Bristol-Myers Squibb, Boehringer Ingelheim, Eli Lilly, Guerbet, Janssen, Merck Serono, Novartis, NovoNordisk, Orion, Pfizer, Roche, Sanofi, SGS, Takeda and Vetter.

 

Mode of Interaction
In 2018, we launched an exchange platform specifically focused on QC lab excellence. The platform allows the participants to share and learn from successful practices of pharmaceutical companies. It combines presentations, workshops and in-depth discussions between global QC lab specialist and network excellence leaders with other specialists from pharmaceutical companies. In total, three 2-days meetings per year are planned.

 

Objective
We want to enable the industry to discuss the exchange topics that are most relevant for the participants. The participants are able to define the topics themselves. Our goal is to allow better problem solving in each of the participants' organizations. The focus topics in year included performance management, work & schedule planning, and digitalization.

 

Timeline
The first 2019 meeting of the exchange platform will be announced here shortly.

If you are interested to learn more about the exchange platform please contact Stephan Köhler.